Literature DB >> 28590964

OVERVIEW OF THE COMPLICATIONS OF HIGH MYOPIA.

Yasushi Ikuno1.   

Abstract

High myopia is very common and one of the major causes of social blindness, especially in East Asian countries. It is characterized by axial length elongation, and induces various specific complications, including cataract formation, retinal detachment from peripheral retinal tears, myopic foveoschisis, macular hole with or without retinal detachment, peripapillary deformation, dome-shaped macula, choroidal/scleral thinning, myopic choroidal neovascularization, and glaucoma. This article will review these complications and discuss the current concepts relating to these complications and their treatments.
CONCLUSION: This information will be helpful for the daily practice of treating myopic eyes.

Entities:  

Mesh:

Year:  2017        PMID: 28590964     DOI: 10.1097/IAE.0000000000001489

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  81 in total

1.  Tricyclic antidepressant amitriptyline inhibits autophagic flux and prevents tube formation in vascular endothelial cells.

Authors:  Yinglu Guan; Xiang Li; Michihisa Umetani; Krishna M Boini; Pin-Lan Li; Yang Zhang
Journal:  Basic Clin Pharmacol Toxicol       Date:  2018-11-15       Impact factor: 4.080

2.  Growth curves of myopia-related parameters to clinically monitor the refractive development in Chinese schoolchildren.

Authors:  Pablo Sanz Diez; Li-Hua Yang; Mei-Xia Lu; Siegfried Wahl; Arne Ohlendorf
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2019-03-23       Impact factor: 3.117

3.  Long-term outcomes of patients with myopic traction maculopathy after phacoemulsification for incident cataract.

Authors:  Lei Cai; Zhongcui Sun; Diwen Guo; Qi Fan; Xiangjia Zhu; Jin Yang; Yi Lu
Journal:  Eye (Lond)       Date:  2019-04-05       Impact factor: 3.775

4.  A novel surgical technique of internal limiting membrane peeling for high myopic foveoschisis: a wide range of whole piece consecutive peeling without preservation of epi-fovea.

Authors:  Shuai He; Tong Su; Zhong-Yi Zhou; Xiao-Meng Li; Wu Xu; Qing-Hua Qiu
Journal:  Int J Ophthalmol       Date:  2022-02-18       Impact factor: 1.779

5.  Weekly Changes in Axial Length and Choroidal Thickness in Children During and Following Orthokeratology Treatment With Different Compression Factors.

Authors:  Jason K Lau; Kin Wan; Sin-Wan Cheung; Stephen J Vincent; Pauline Cho
Journal:  Transl Vis Sci Technol       Date:  2019-07-23       Impact factor: 3.283

6.  Protective effects of riboflavin-UVA-mediated posterior sclera collagen cross-linking in a guinea pig model of form-deprived myopia.

Authors:  Ding Han; Mei-Nan He; Ying Zhu; Yan Zhang; Rui-Hua Wei
Journal:  Int J Ophthalmol       Date:  2021-03-18       Impact factor: 1.779

7.  Violet light suppresses lens-induced myopia via neuropsin (OPN5) in mice.

Authors:  Xiaoyan Jiang; Machelle T Pardue; Kiwako Mori; Shin-Ichi Ikeda; Hidemasa Torii; Shane D'Souza; Richard A Lang; Toshihide Kurihara; Kazuo Tsubota
Journal:  Proc Natl Acad Sci U S A       Date:  2021-06-01       Impact factor: 11.205

8.  Prevalence and risk factors of refractive error in Qinghai, China: a cross-sectional study in Han and Tibetan adults in Xining and surrounding areas.

Authors:  Meng Wang; Linyang Gan; Jiantao Cui; Guangliang Shan; Ting Chen; Xianghua Wang; Yuhan Wang; Li Pan; Zhanquan Li; Sen Cui; Airong Yang; Wenfang Li; Guoqiang Jia; Ximing Han; Huijing He; Yong Zhong; Jin Ma
Journal:  BMC Ophthalmol       Date:  2021-06-19       Impact factor: 2.209

9.  Differential Distributions of Myopia Severity in Younger and Older Individuals with Rhegmatogenous Retinal Detachment.

Authors:  Elvioza Elvioza; Denny Agustiningsih; Suhardjo Prawiroranu; Muhammad Bayu Sasongko
Journal:  Clin Ophthalmol       Date:  2021-07-08

10.  Intravitreal brimonidine inhibits form-deprivation myopia in guinea pigs.

Authors:  Yifang Yang; Junshu Wu; Defu Wu; Qi Wei; Tan Zhong; Jun Yang; Xiaowei Yang; Meizhen Zeng; Xingwu Zhong
Journal:  Eye Vis (Lond)       Date:  2021-07-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.